Tag Archives: Remogliflozin Etabonate

Glenmark Pharma gets USFDA nod to market diabetes treatment drug

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT  – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indian pharma major Glenmark Pharmaceuticals Ltd said of having got US FDA (Food & Drugs Administration) nod to market diabetes treatment drug. Press-release titled, “Glenmark receives approval for combination of Remogliflozin Etabonate and Metformin Hydrochloride for adults

Torrent Pharma inks diabetic drug marketing pact with Glenmark Pharma

AHMEDABAD | MUMBAI | RAJKOT –  In a press release submitted to the Indian Bourses by Glenmark Pharma it said that, Ahmedabad headquartered Torrent Pharmaceuticals and Glenmark Pharmaceuticals Ltd have inked agreement for co-marketing of diabetic treatment drug Remogliflozin Etabonate in India. The press release submitted to the Indian Exchanges on Thursday read that, Glenmark

Do NOT follow this link or you will be banned from the site!